United Therapeutics Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$790,200	$799,500	$798,600	$794,400
Gross Profit	686,800	698,600	711,000	701,900
EBITDA	524,300	462,900	436,800	382,800
EBIT	447,100	441,000	415,700	417,400
Net Income	364,300	338,700	309,500	322,200
Net Change In Cash	790,200	799,500	798,600	794,400
Free Cash Flow	173,300	351,600	129,500	386,300
Cash	1,557,100	1,136,600	1,593,100	1,899,900
Basic Shares	47,900	47,300	48,300	48,600

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,182,700	$2,877,400	$2,327,500	$1,936,300
Gross Profit	2,798,300	2,567,700	2,070,000	1,789,600
EBITDA	1,819,000	1,654,400	1,386,800	1,040,300
EBIT	1,733,400	1,581,900	1,333,600	989,000
Net Income	1,334,700	1,195,100	984,800	727,300
Net Change In Cash	3,182,700	2,877,400	2,327,500	1,936,300
Cost of Revenue				66,400
Free Cash Flow	1,040,700	1,080,600	747,600	663,700
Cash	1,557,100	1,697,200	1,207,700	961,200
Basic Shares	47,900	48,500	49,700	48,500